TLR3 and its roles in the pathogenesis of type 2 diabetes

Z Sepehri; Z Kiani; F Javadian; A Akbar Nasiri; F Kohan; S Sepehrikia; S Javan Siamardi; H Aali; H Daneshvar; D Kennedy

Issue

Vol. 61 No. 3: Issue 3

Issue Published : May 18, 2016

The undersigned hereby assign all rights, included but not limited to copyright, for this manuscript to CMB Association upon its submission for consideration to publication on Cellular and Molecular Biology. The rights assigned include, but are not limited to, the sole and exclusive rights to license, sell, subsequently assign, derive, distribute, display and reproduce this manuscript, in whole or in part, in any format, electronic or otherwise, including those in existence at the time this agreement was signed. The authors hereby warrant that they have not granted or assigned, and shall not grant or assign, the aforementioned rights to any other person, firm, organization, or other entity. All rights are automatically restored to authors if this manuscript is not accepted for publication.

TLR3 and its roles in the pathogenesis of type 2 diabetes

Z Sepehri

Zabol University of Medical Sciences Department of Internal Medicine Zabol Iran

Z Kiani

Kerman University of Medical Sciences Department of Medicine Kerman Iran

F Javadian

Zabol University of Medical Sciences Zabol medicinal plant research center Zabol Iran

A Akbar Nasiri

Zabol University of Medical Sciences Department of Anesthesiology Zabol Iran

F Kohan

Zabol University of Medical Sciences General Physician Zabol Iran

S Sepehrikia

Zabol University of Medical Sciences General Physician Zabol Iran

S Javan Siamardi

Zabol University of Medical Sciences Department of Health Zabol Iran

H Aali

Zabol University of Medical Sciences Department of Internal Medicine Zabol Iran

H Daneshvar

Faculty of Medicine, Kerman University of Medical Sciences Department of Immunology Kerman Iran

D Kennedy

Griffith University School of Natural Sciences and Eskitis Institute for Drug Discovery Brisbane Australia

Corresponding Author(s) : Z Sepehri

Cellular and Molecular Biology, Vol. 61 No. 3: Issue 3
Article Published : June 17, 2015

Abstract

Type 2 diabetes (T2D) is the most prevalent non-infectious disease and leads to several complications including nephropathy and retinopathy. The mechanisms and signaling molecules responsible for the development and progression of T2D, as well as its associated complications are yet to be identified. It would appear that genetic backgrounds and immunological parameters of people susceptible to T2D may play important roles in induction of T2D. TLRs participate in several cellular pathways which can induce activation of proliferation. However, in contradiction, these pathways can also be associated with apoptosis. The multiple roles of TLRs and their signaling molecules associated with T2D pathways makes them candidates for the induction of immune-regulated diseases like T2D. TLR3 has been identified as an intracellular ligand and subsequently activates signaling molecules via the TRIF pathway. Therefore, the alteration of expression of TLR3 and their functions may lead to inappropriate induction of immune system functions that are related to T2D disease. The aim of this review was to collect recent data regarding the roles of TLR3 in the progression and pathogenesis of T2D.

Keywords

Type 2 Diabetes Toll Like Receptor 3 TRIF.

Sepehri, Z., Kiani, Z., Javadian, F., Akbar Nasiri, A., Kohan, F., Sepehrikia, S., Javan Siamardi, S., Aali, H., Daneshvar, H., & Kennedy, D. (2015). TLR3 and its roles in the pathogenesis of type 2 diabetes. Cellular and Molecular Biology, 61(3), 46–50. Retrieved from https://mail.cellmolbiol.org/index.php/CMB/article/view/668